16 January 2008
Global Health Advocacy and Activism Department of Global Health, George Washington University
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...is document has been updated: Version 6 June 2022.
more
English Analysis on World and 19 other countries about Agriculture, Food and Nutrition and Drought; published on 13 Jan 2021 by FAO
Данный документ предназначен в первую очередь для работников здравоохранения. Поскольку социальные детерминанты нарушений психического здоровья и психосоциаль...ых проблем относятся ко многим различным секторам, каждый второй инструмент из предложенного набора охватывает вопросы оценки ОПЗПП, актуальные не только для здравоохранения, но и для других секторов. Настоящий документ призван помочь вам в сборе необходимой информации для того, чтобы оказывать более действенную поддержку людям, пострадавшим от гуманитарных кризисов.
Assessing mental health and psychosocial needs and resources: toolkit for humanitarian setting
more
Primary care can play a significant role in the COVID-19 response by differentiating patients with respiratory symptoms from those with COVID-19, making an early diagnosis, helping vulnerable people cope with their anxiety about the virus, and reducing the demand for hospital services. This document... provides national and subnational health managers, as well as staff at primary care facilities, with interim guidance on timely, effective and safe supportive management of patients with suspected and confirmed COVID-19 at the primary care level; and delivery of essential health services at the primary care level during the COVID-19 outbreak
more
This summary brief highlights key messages from the updated World Health Organization’s recommendation on tranexamic acid (TXA) for the treatment of postpartum haemorrhage (PPH), including policy and program implications for translating the TXA recommendation into action at the country level. In 2...012, WHO published recommendations for the prevention and treatment of postpartum haemorrhage, including a recommendation on the use of TXA for treatment of PPH. The 2017 updated WHO Recommendation on TXA is based on new evidence on use of TXA for treatment of PPH. This summary brief is intended for policy-makers, programme managers, educators and providers.
more
This brief focuses specifically on the Grand Nord (Great North): the Beni and Lubero territories of northern North Kivu that are the epicentre of the outbreak. Further participatory enquiry should be undertaken with the affected populations, but given ongoing transmission, conveying key consideratio...ns and immediate recommendations have been prioritised.
This brief is based on a rapid review of existing published and grey literature, professional ethnographic research in DRC, personal communication with administrative and health officials and practitioners in the country, and experience of previous Ebola outbreaks.
more
Report on Main Findings
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD research in Myanmar; and 3) additional reviews of Myanmar ethical committee inqui...ries and postgraduate research on NCDs in Myanmar. This report outlines the key findings from the three components including a synthesis of the key outcomes from the literature review and qualitative interviews, and an assessment of the gaps in the evidence against a framework of evidence needs.
more
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
Supplement Article
WHO Guidelines for HIV PEP • CID 2015:60 (Suppl 3), S161 - S164
This Poster is available in English, French, Spanish, Russian, Chinese, Portuguese, Hausa and Arabic
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
SAHARA-J: Journal
of Social Aspects of HIV/AIDS, 13:1, 1-7, DOI: 10.1080/17290376.2015.1123646
country brief, Syrian Arab Republic